European Hematology Association

Tweet this page
<
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
>
Registration as it was on 01 Dec 2023
How to read and use this data card.
Download this datacard

Overview

Lobbying Costs

200,000€ - 299,999€

Financial year: Jan 2022 - Dec 2022

Lobbyists (Full time equivalent)

5 Fte (5)

Lobbyists with EP accreditation

0

High-level Commission meetings

0

Lobbying Costs over the years

  • Info

    European Hematology Association   (EHA)

    EU Transparency Register

    91666778136-14 First registered on 23 Feb 2012

    Goals / Remit

    The European Hematology Association (EHA) promotes excellence in patient care, research and education in hematology.

    Main EU files targeted

    EU Pharmaceutical legislation
    Horizon Europe / Cancer Mission
    Europe's Beating Cancer Plan
    Clinical Trials Regulation
    SoHO Regulation
    HTA Regulation
    In Vitro Diagnostic Medical Devices Regulation (IVDR)
    Professional Qualifications Directive
    European Health Data Space

    Address

    Head Office
    Koninginnegracht 12b
    The Hague 2514 AA
    NETHERLANDS
    EU Office
    Koninginnegracht 12b
    The Hague 2514 AA
    NETHERLANDS

    Website

  • People

    Total lobbyists declared

    5

    Employment timeLobbyists
    100%5

    Lobbyists (Full time equivalent)

    5

    Lobbyists with EP accreditation

    All Lobbyists with EP accreditation over time

    0 accreditations were / are live (in bold) for the selected state of 26 Apr 2024

    Name Start date End Date
    Ms Catharina Smand 06 Sep 2016 03 Sep 2017
    Mr Robin Doeswijk 05 Sep 2016 03 Sep 2017
    Mr Thomas Duijvené de Wit 25 Nov 2015 16 Sep 2016
    Ms Fleur de Haas 21 Nov 2015 06 Sep 2016
    Ms Fleur de Haas 05 Nov 2014 16 Oct 2015
    Mr Thomas Duijvené de Wit 08 Aug 2014 06 Aug 2015
    Mr Thomas Duijvené de Wit 13 Apr 2013 12 Apr 2014
    Mr Thom Duyvené de Wit 21 Aug 2012 24 Feb 2013

    Complementary Information

    None declared

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories

    Category

    Trade unions and professional associations

  • Networking

    Affiliation

    BioMed Alliance
    European Cancer Organisation (ECO)
    European Alliance for Personalised Medicine (EAPM)
    EMA Healthcare Professionals' Working Party (HCPWP)
    EMA HCP Policy Officers Group
    EMA Cancer Medicines Forum
    Rare Cancers Europe, hosted by ESMO: https://www.esmo.org/policy/rare-cancers-working-group/about-rare-cancers-working-group
    European Network for TYA with Cancer (ENTYAC), hosted by SIOP Europe: https://siope.eu/news/discover-ENTYAC-Oct22/
    Coalition for Reducing Bureaucracy in Clinical Trials, hosted by EHA: https://bureaucracyincts.eu/

    Member organisations

    EHA members are individuals, not organizations. Whilst not a federation, EHA collaborates closely with the national societies of hematology, as well as with the association of specialist haematology nurses HNHCP and the European umbrella organizations of hematology patients assembled in the EHA Patient Advocacy Committee (EHA PAC).
    See for the relevant listings https://ehaweb.org/advocacy/partnerships/

  • Financial Data

    Interests represented

    Promotes their own interests or the collective interests of their members

    Closed financial year

    Jan 2022 - Dec 2022

    Lobbying costs for closed financial year

    200,000€ - 299,999€

    Major contributions in closed year

    None declared

    Major contributions in current year

    TypeNameAmount
    Grant EU4Health 38,407€

    Intermediaries for closed year

    None declared

    Intermediaries for current year

    None declared

    Closed year Costs

    200,000€ - 299,999€

    Other financial info

    None declared

  • EU Structures

    Groups (European Commission)

    none

    Groups (European Parliament)

    N/A

    Communication activities

    EHA position papers and policy statements for policymakers and MEPs; responding to consultations; dialogue with and scientific advice to regulators (mostly EMA) and HTA bodies; participation in policy meetings and stakeholder groups; joint positioning and meetings with other medical societies, patient organizations and other stakeholders; participation in or support for EU-funded projects; cross-disciplinary advocacy campaigns; policy & regulatory track at annual congress

    Other activities

    None declared

  • Meetings

    Meetings

    None declared

Download this datacard